Hepatocytes only weakly express these isoforms (Figure 2B,C) but immune cells producing abnormal levels of S100A8/A9 in the tumor microenvironment may deeply affect tumor initiation and progression [155]. Here, IGKV1D-22 is linked to neoplasm.